Filing Details

Accession Number:
0001213900-23-075087
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-07 17:38:03
Reporting Period:
2023-09-05
Accepted Time:
2023-09-07 17:38:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1812173 Vicarious Surgical Inc. RBOT Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1885525 John William Kelly C/O Vicarious Surgical Inc.
78 Fourth Avenue
Waltham MA 02451
Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-09-05 6,461 $0.96 550,050 No 4 S Direct
Class A Common Stock Disposition 2023-09-05 4,880 $0.98 545,170 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.
  2. This figure is the weighted average sales price of multiple trades ranging from $0.9481 to $0.9915 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
  3. These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.
  4. This figure is the weighted average sales price of multiple trades ranging from $0.961 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.